Skip to content

Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients

Prospective Evaluation of Adherence to Recommended Activity Regimen in Patients Following Treatment of Stages II and III Colorectal Cancer.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00977613
Enrollment
50
Registered
2009-09-16
Start date
2007-04-30
Completion date
2010-05-31
Last updated
2011-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer (CRC)

Keywords

Treated Stage 2 and Stage 3 colorectal cancer

Brief summary

Given the apparent effect of 18 metabolic equivalent task-hours of activity/week in improving disease free survival in patients with treated stage 3 colon cancer and the survival benefit of exercise demonstrated in patients with stage II and III colorectal cancer, the primary objective is to evaluate compliance at 6 months with post-treatment recommendations for a minimum of 18 metabolic units of physical activity each week in patients who have completed therapy for stage 2 and stage 3 colorectal cancer.

Interventions

motivational counseling to exercise a minimum 18 metabolic hours per week

Sponsors

Beth Israel Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients with histological confirmation of stage 2 or stage 3 colorectal cancer. 2. Ability to sign written informed consent. 3. WHO performance status of 2 or better. 4. No evidence of recurrent disease or death prior to second questionnaire. 5. Patients with declining physical activity within 90 days of second physical activity assessment will be excluded. There are no

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Maintained an Exercise Regimen Average of 18 Metabolic Units (MET) Per Week or Greater6 monthsOne MET is the energy expenditure for sitting quietly for 1 hour. MET scores for walking were assigned based on the pace and duration reported. For other activities, a leisurely to moderate intensity score was selected. The scores for MET-hours per week for each activity were calculated from the reported hours per week engaged in that activity multiplied by the assigned MET score, and individual activities were summed to derive a total MET-hours per week.

Secondary

MeasureTime frame
Overall Survivalafter 6 months
Disease-free Survivalafter 6 months
Recurrence-free Survivalafter 6 months

Countries

United States

Participant flow

Recruitment details

Enrolled subjects were ambulatory patients completing treatment for colorectal cancer (CRC) from April 2007 through August 2009 at the Continuum Cancer Centers-Beth Israel Medical Center and St. Luke's Roosevelt Hospital.

Pre-assignment details

Subjects were counseled to exercise at least 18 metabolic equivalent units weekly. Subjects were provided with information on the metabolic equivalents of common forms of exercise.

Participants by arm

ArmCount
Single Arm, Life Style Counseling
Patients with stage II or III colon or rectal cancer were accrued by physician screening at a visit three to four months following surgical resection. At the time of initial subject study enrollment, and at each follow-up visit, the physician or nurse administering the questionnaire was to review the benefit of adjuvant exercise and encourage patients to continue or increase their weekly activity in order to maintain at least 18 MET/week.
50
Total50

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up16

Baseline characteristics

CharacteristicSingle Arm, Life Style Counseling
Age, Customized
Age greater than 18 years
50 participants
Region of Enrollment
United States
50 participants
Sex/Gender, Customized
Female
21 participants
Sex/Gender, Customized
Male
26 participants
Sex/Gender, Customized
Unknown
3 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Number of Participants Who Maintained an Exercise Regimen Average of 18 Metabolic Units (MET) Per Week or Greater

One MET is the energy expenditure for sitting quietly for 1 hour. MET scores for walking were assigned based on the pace and duration reported. For other activities, a leisurely to moderate intensity score was selected. The scores for MET-hours per week for each activity were calculated from the reported hours per week engaged in that activity multiplied by the assigned MET score, and individual activities were summed to derive a total MET-hours per week.

Time frame: 6 months

Population: 34 of the 50 enrolled subjects had at least 6 months of follow-up. There was no evaluable data for the remaining 16 subjects.

ArmMeasureValue (NUMBER)
Single Arm, Life Style CounselingNumber of Participants Who Maintained an Exercise Regimen Average of 18 Metabolic Units (MET) Per Week or Greater18 participants
Secondary

Disease-free Survival

Time frame: after 6 months

Secondary

Overall Survival

Time frame: after 6 months

Secondary

Recurrence-free Survival

Time frame: after 6 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026